MOLN.SW
Molecular Partners AG
Price:  
4.96 
CHF
Volume:  
3,284.00
Switzerland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MOLN.SW EV/EBITDA

-201.6%
Upside

As of 2024-12-13, the EV/EBITDA ratio of Molecular Partners AG (MOLN.SW) is -1.65. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MOLN.SW's latest enterprise value is 120.20 mil CHF. MOLN.SW's TTM EBITDA according to its financial statements is -73.06 mil CHF. Dividing these 2 quantities gives us the above MOLN.SW EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 3.2x - 7.8x 3.4x
Forward P/E multiples 2.8x - 8.5x 3.4x
Fair Price (4.64) - (13.84) (5.04)
Upside -193.6% - -379.0% -201.6%
4.96 CHF
Stock Price
(5.04) CHF
Fair Price

MOLN.SW EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-11-21 -1.57
2024-11-20 -1.56
2024-11-19 -1.61
2024-11-18 -1.74
2024-11-15 -1.59
2024-11-14 -1.59
2024-11-13 -1.77
2024-11-12 -1.72
2024-11-11 -1.87
2024-11-08 -1.93
2024-11-07 -1.77
2024-11-06 -1.94
2024-11-05 -1.56
2024-11-04 -1.70
2024-11-01 -1.86
2024-10-31 -1.73
2024-10-30 -1.89
2024-10-29 -1.97
2024-10-28 -2.06
2024-10-25 -2.04
2024-10-24 -1.93
2024-10-23 -1.70
2024-10-22 -2.07
2024-10-21 -2.02
2024-10-18 -1.39
2024-10-17 -1.27
2024-10-16 -1.29
2024-10-15 -1.26
2024-10-14 -1.31
2024-10-11 -1.21
2024-10-10 -1.25
2024-10-09 -1.25
2024-10-08 -1.33
2024-10-07 -1.21
2024-10-04 -1.23
2024-10-03 -1.17
2024-10-02 -1.20
2024-10-01 -1.17
2024-09-30 -1.35
2024-09-27 -1.36
2024-09-26 -1.16
2024-09-25 -1.17
2024-09-24 -1.19
2024-09-23 -1.18
2024-09-20 -1.21
2024-09-19 -1.21
2024-09-18 -1.18
2024-09-17 -1.32
2024-09-16 -1.35
2024-09-13 -1.45